Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2023 Dec 4;17(12):e0011816. doi: 10.1371/journal.pntd.0011816

Trichinella spiralis cathepsin L damages the tight junctions of intestinal epithelial cells and mediates larval invasion

Ruo Dan Liu 1, Xiang Yu Meng 1, Chen Le Li 1, Xin Zhi Lin 1, Qiu Yi Xu 1, Han Xu 1, Shao Rong Long 1, Jing Cui 1,*, Zhong Quan Wang 1,*
Editor: Krystyna Cwiklinski2
PMCID: PMC10721182  PMID: 38048314

Abstract

Background

Cathepsin L, a lysosomal enzyme, participates in diverse physiological processes. Recombinant Trichinella spiralis cathepsin L domains (rTsCatL2) exhibited natural cysteine protease activity and hydrolyzed host immunoglobulin and extracellular matrix proteins in vitro, but its functions in larval invasion are unknown. The aim of this study was to explore its functions in T. spiralis invasion of the host’s intestinal epithelial cells.

Methodology/principal findings

RNAi significantly suppressed the expression of TsCatL mRNA and protein with TsCatL specific siRNA-302. T. spiralis larval invasion of Caco-2 cells was reduced by 39.87% and 38.36%, respectively, when anti-TsCatL2 serum and siRNA-302 were used. Mice challenged with siRNA-302-treated muscle larvae (ML) exhibited a substantial reduction in intestinal infective larvae, adult worm, and ML burden compared to the PBS group, with reductions of 44.37%, 47.57%, and 57.06%, respectively. The development and fecundity of the females from the mice infected with siRNA-302-treated ML was significantly inhibited. After incubation of rTsCatL2 with Caco-2 cells, immunofluorescence test showed that the rTsCatL2 gradually entered into the cells, altered the localization of cellular tight junction proteins (claudin 1, occludin and zo-1), adhesion junction protein (e-cadherin) and extracellular matrix protein (laminin), and intercellular junctions were lost. Western blot showed a 58.65% reduction in claudin 1 expression in Caco-2 cells treated with rTsCatL2. Co-IP showed that rTsCatL2 interacted with laminin and collagen I but not with claudin 1, e-cadherin, occludin and fibronectin in Caco-2 cells. Moreover, rTsCatL2 disrupted the intestinal epithelial barrier by inducing cellular autophagy.

Conclusions

rTsCatL2 disrupts the intestinal epithelial barrier and facilitates T. spiralis larval invasion.

Author summary

Trichinosis is a severe zoonotic disease that affects humans by eating raw or semi-raw meat products containing T. spiralis larvae. The intestinal mucosal barrier is the initial defense against T. spiralis infection and the main point of contact between the host and the parasite. Beyond the mechanical action, the protease released by the worm are essential for T. spiralis invasion of the host small intestine. Cathepsins play a crucial role in the migration of Fasciola hepatica and the invasion of Schistosoma japonicum, essential for their parasitism in the host. Nevertheless, the specific functions of T. spiralis cathepsin L during the worm’s invasion of the intestinal mucosa remain unexplored. In this study, the TsCatL gene was silenced using siRNA, which inhibited worm invasion of Caco-2 cells, impaired worm development, and decreased female fertility. Incubation of rTsCatL2 with Caco-2 cells resulted in the translocation of cell tight junction proteins (claudin 1, occludin and zo-1), adhesion junction protein (e-cadherin) and extracellular matrix protein (laminin) into the cytoplasm or the nucleus, a reduction in claudin 1 expression and cellular autophagy, leading to disruption of the intestinal epithelial barrier. This study provides a novel target for developing anti-trichinosis vaccines and drugs.

Introduction

Trichinosis is a severe foodborne zoonotic disease that affects humans who consume raw or semi-raw meat products containing Trichinella spiralis larvae [1]. Larval invasion into the host’s intestinal mucosa for further development is essential in T. spiralis infection [2]. The intestinal mucosal barrier constitutes the primary natural defense against T. spiralis infection and serves as the main site of interaction between the host and the parasite. The intestinal mucosal barrier consists of mechanical, chemical, immune, and biological barriers. The mechanical barrier mainly comprises intestinal epithelial cells (IEC) and cell junctions. IEC junctions contain tight junctions (TJ), adhesion junctions (AJ), gap junctions (GJ), and desmosomes [3]. Intestinal epithelial TJ proteins comprise two major groups: transmembrane proteins and cytoplasmic proteins, primarily responsible for "barrier" and "defence" functions. Transmembrane proteins can regulate the transport of substances in the paracellular pathway, and cytoplasmic proteins mainly regulate the free diffusion of lipids and proteins. The TJ proteins mainly include claudin, occludin, zonula occludens protein 1 (zo-1) and β-catenin. The TJ proteins between cells close the apical spaces between epithelial cells and maintain the integrity of the intestinal mucosal barrier. The TJ proteins of epithelial cells are a dynamic barrier subject to regulation. Various endogenous or exogenous stimuli can compromise barrier integrity through diverse pathways, such as altering the content and distribution of TJ proteins, inducing cytoskeletal protein rearrangements, or modifying the phosphorylation of TJ proteins [4].

During T. spiralis invasion of the host small intestine, besides mechanical effect, the protease secreted by the worm also play a crucial role [5,6]. When T. spiralis larvae are co-cultured with IEC monolayers, the worms secrete a variety of proteases that damage the intestinal epithelium’s integrity and make it easier for the worms to invade the IEC [7,8]. Serine protease of T. spiralis muscle larvae (ML) can reduce TJ proteins expression and disrupt the Caco-2 cell monolayers through the mitogen-activated protein kinase (MAPK) signaling pathway [9]. The expressions of occludin, claudin 1, and e-cadherin were downregulated, while claudin-2 was upregulated in the T. spiralis intestinal infective larvae (IIL) by cysteine and serine proteases [10]. The expressions of occludin and claudin-3 in mouse intestinal epithelium were downregulated and claudin-2 expression was upregulated 2 days after Trichinella infection, which was associated with increased permeability of the small intestinal epithelium [11]. In addition, serine proteases produced by Trichuris muris can degrade the intestinal mucus barrier [12]. Giardipain-1, a cysteine peptidase produced by Giardia duodenalis trophozoites, causes the monolayer of intestinal epithelial cells to degrade the TJ proteins occludin and claudin 1 [13]. The T. spiralis cathepsin L (TsCatL) protein consists of a transmembrane helix, an inhibitor_I29 domain and a mature Pept_C1 domain. TsCatL two domains (TsCatL2) was cloned and expressed in Escherichia coli Rosetta-gami B (DE3) [14]. Recombinant TsCatL2 has cysteine protease activity and can hydrolyze host hemoglobin, serum albumin, immunoglobulin and extracellular matrix proteins in vitro with host-specific hydrolytic activity, indicating that TsCatL is a crucial digestive enzyme in T. spiralis [14]. In contrast, there are no relevant studies on the effect of TsCatL on epithelial barrier damage.

This study explored the role of TsCatL in invading the host’s intestinal mucosa through RNA interference (RNAi) silencing of TsCatL in worms. Additionally, it investigated TsCatL’s impact on disrupting the epithelial barrier through the interaction of rTsCatL2 with Caco-2 cells in vitro.

Materials and methods

Parasites, animals and ethics statement

Trichinella spiralis (ISS534) was sourced from pigs in Nanyang, Henan Province, and maintained in BALB/c. Specific pathogen free (SPF) female BALB/c, aged 4 to 6 weeks, were obtained from Huaxing Experimental Animal Center (No. SCXK 2019–0002). All animal experiments were approved by the Life Science Ethics Committee of Zhengzhou University.

Preparation of ML and soluble protein

BALB/c mice infected by gavage with 300 T. spiralis were decapitated and killed after 42 days of infection. Skin, guts and fat were removed from the mice and added to a pepsin-hydrochloric acid artificial digestion solution and digested on a constant temperature shaker at 42°C for 4 ~ 6 h until no intact muscle was present, and ML were collected by natural sedimentation and a modified Baermann’s method [15,16]. Soluble proteins were collected as follows: T. spiralis was first put through a grinder at 4°C for 1 min, followed by a 10 min sonication and centrifugation at 12,000 g for 30 min [7]. The supernatant was T. spiralis soluble protein. Protein concentration was determined using the BCA assay kit (Beyotime, China).

Preparation of rTsCatL2, anti-rTsACatL2 serum and experimental cells

The pMAL-c2X/TsCatL2 recombinant plasmid were stored in our laboratory. Recombinant proteins (rTsCatL2) and MBP were expressed in Escherichia coli Rosetta-gami B (DE3), purified with amylose resin, and detected in previous studies [14]. To eliminate endotoxin interference in rTsCatL2, endotoxin removal resin (Thermo Fisher, USA) was used. Mouse anti-rTsACatL2 serum, anti-rTsASP2 serum and anti-MBP serum were produced by immunizing BALB/c mice with rTsCatL/rTsASP2/MBP mixed with adjuvant via intramuscular injection and collecting the blood of the mice to isolate the serum [6,14]. The human colonic epithelial cell line Caco-2 and the mouse myogenic cell line C2C12 were obtained from the Cell Resource Centre, Chinese Academy of Sciences.

Electroporation of T. spiralis ML with siRNA

Three small interfering RNA (siRNA) sequences targeting TsCatL were designed using the siDirect version 2.0 online tool (http://sidirect2.rnai.jp). A control siRNA unrelated to T. spiralis was used as a control (Table 1). All siRNAs were synthesized by Sangon Biotech (Shanghai, China). The RNA interference (RNAi) experiment was divided into 5 groups: siRNA-302 group, siRNA-775 group, siRNA-1077 group, control-siRNA group and PBS group.

Table 1. TsCatL-specific siRNA and control-siRNA sequences.

siRNA name Sense (5′-3′) Antisense (5′-3′)
TsCatL siRNA-302 GAAAUAUACGGAAAAACGUTT ACGUUUUUCCGUAUAUUUCTT
TsCatL siRNA-775 CGCUUUUGAGUAUGUCAAATT UUUGACAUACUCAAAAGCGTT
TsCatL siRNA-1077 CAUUGAAAGGAAAGGAUUATT UAAUCCUUUCCUUUCAAUGTT
Control siRNA AUCGGCUACCAAGUCAUACTT GUAUGACUUGGUAGCCGAUTT

T. spiralis ML were washed with sterile PBS (more than 16 times) and then resuspended in electroporation buffer containing 5 μM siRNA. Electroporation was performed at 125 V for 25 ms using a Gene Pulse Xcell System (Bio-Rad, USA). Subsequently, the larvae were incubated in 1640 medium at 37°C in a 5% CO2 for 2 h [6]. Fetal bovine serum was added to the medium cultured for 1 ~ 5 days. Each experiment was done in triplicate.

Transcription and expression of TsCatL2 after siRNA transfection

T. spiralis ML RNA was extracted using trizol (Tiangen, China), reverse transcribed into cDNA (PrimeScriPt RT reagent kit, Takara, Japan), and the qPCR reaction system was configured using SYBR Green qPCR Master Mix (Topscience, China). The qPCR amplification of TsCatL and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) was performed using a 7500 Fast Real-time PCR System (Applied Biosystems, USA). The qPCR primers for TsCatL2 gene were 5′-TACGGAAAAACGTATGCAAATG-3′ and 5′-CAAATTCTCCATGAGTCAAA TCGG-3′. Specific primers for the GAPDH gene (GenBank: AF452239) were 5′-AGATGCTCCTATGTTGGTTATGGG-3′ and 5′-GTCTTTTGGGTTGCCGTTGTAG-3′ [17]. Finally, the relative quantitative 2-ΔΔCt method was employed to analyze mRNA transcript levels of TsCatL at different time points following siRNA interference [18].

20 μg soluble proteins from the worms were subjected to 10% SDS-PAGE and western blot. Depending on the molecular weight of the proteins, the membranes were incubated with mouse anti-rTsCatL2 serum (1:100), mouse anti-rTsASP2 serum (1:100) and rabbit anti-GAPDH IgG (1:1000) at 4°C overnight, then incubated with HRP-conjugated secondary antibodies (1:5 000, proteintech, USA) and exposure with the efficient chemiluminescence (ECL) solution (meilunbio, China) [19]. And then, the relative intensities of each band were analyzed using the Image J software (National Institutes of Health, USA).

T. spiralis invasion assay in vitro

Caco-2 and C2C12 cells were grown into dense monolayers in 12-well or 12-well plates with slides. T. spiralis ML were incubated in 5% bile saline for 2 h at 37°C. 500 μL of 50°C 1.75% sterile low melting point agarose was mixed with 500 μL of 37°C 1640 medium containing about 50 live or dead worms and rapidly added to the cell surface. Once the semi-solid medium had solidified, the 12-well plates were incubated for 2 h, and the larval invasion into the cells was observed [20]. The semi-solid medium was then removed and the cells were stained with 10 μg/mL propidium iodide (PI) solution on ice for 1 min. After PBS washing, the damage to the cells caused by the worm invasion was observed under the microscope. Subsequently, the cell surface was fixed with 4% paraformaldehyde fixative and incubated with anti-rTsCatL2 serum, Trichinella-infected mouse serum and normal mouse serum, respectively. FITC-conjugated goat anti-mouse IgG was added and incubated for 1 hour at 37°C. The residues of rTsCatL on the cell surface were observed under a fluorescence microscope [21].

In addition, the anti-rTsCatL2 serum, anti-MBP serum, Trichinella-infected serum, normal mouse serum or PBS was added to the semi-solid medium at different dilution ratios to analyze the effect on larval invasion and inhibition. The effect of TsCatL silencing on the invasion rate of worms was examined by adding TsCatL siRNA-302, control-siRNA and PBS electrotransformed worms to a semi-solid medium containing a monolayer of Caco-2 cells, respectively.

Animal experiments analyze the effect of TsCatL on larval development and survival

Ninety BALB/c mice were randomly assigned to the TsCatL siRNA-302, control siRNA and PBS group. The electrotransformed larvae were cultured in 1640 medium for 3 d, and then 200 T. spiralis ML were gavaged into each mouse. IIL and adult worms (AW) were obtained from the mice’s intestines at 24 h and 6 d post-infection and counted and measured [17,22]. The 6d females were placed in 48-well plates for a further 48 h and the newborn larvae (NBL) generated by each female were counted and measured. At 35 d after Trichinella infection of the mice, the ML was obtained from mouse muscle and the number of worms per gram of muscle was calculated.

Effect of rTsCatL2 on Caco-2 cell junctions

Caco-2 and C2C12 cells were grown into dense monolayers on glass coverslips in 12-well plates. rTsCatL2, MBP, E64-treated rTsCatL2, heat-treated rTsCatL2 or PBS was acidified in pH 4.5 buffer for 30 min, added to pH 6.5 PBS to adjust the final concentration to 10 μg/mL, then added to the surface of Caco-2 cells and incubated in a 5% CO2 incubator for various times (1 ~ 60 min) [10,13]. Cellular immunofluorescence assays were performed by sequentially fixing the incubated slides with 4% paraformaldehyde for 10 min, antigen repair buffer (100 mM Tris, 5% [w/v] urea, pH 9.5) for 10 min at 95°C, permeabilizing PBS (0.25% Triton X-100) for 10 min, and then incubating the slides with blocking solution (1% BSA, 22.52 mg/mL glycine PBST) for 30 min. After blocking, primary antibodies, including mouse anti-rTsCatL2 serum, mouse anti-MBP serum, rabbit anti-claudin 1, e-cadherin, occluding, zo-1, fibronectin or laminin antibodies (Abcam, USA) were added and incubated for 60 min. A 1:100 dilution of FITC-goat anti-mouse IgG (Proteintech, USA) or FITC-goat anti-rabbit IgG (Proteintech, USA) was incubated for 60 min [23]. Finally, the PI staining solution was added to stain nuclei for 5 min and the sections were embedded in 30% glycerol for observation under a fluorescence microscope.

Changes in cellular protein expression were detected by collecting cells after incubation, extracting cellular proteins with radio immunoprecipitation assay (RIPA) lysate (Beyotime, China), determining protein concentrations and then performing SDS-PAGE and western blot. Depending on the molecular weight of the proteins, polyvinylidene fluoride (PVDF) membranes were incubated with rabbit anti-claudin 1, e-cadherin, occludin, laminin or collagen-I antibodies (Abcam, USA), and mouse anti-ß-actin antibodies (Servicebio, China) were incubated overnight at 4°C, followed by incubation with HRP-goat anti-rabbit/mouse IgG (Proteintech, USA). Exposure was performed using the ECL chemiluminescence kit (Meilunbio, China).

Co-IP

Caco-2 cells were incubated with 10 μg/mL rTsCatL2, MBP or PBS for 30 min. The cells were washed with PBS and lysed with inhibitor-containing RIPA lysate (Beyotime, China) to obtain cell-soluble proteins. After the removal of non-specific binding, 2 μg anti-rTsCatL2 IgG was added to the rTsCatL2 group, 2 μg anti-MBP IgG was added to the MBP group and normal mouse IgG was added to the PBS group and shaken slowly at 4°C overnight. The next day, 20 μL of Protein A/G PLUS agarose (1:100; Santa Cruz, USA) was added to each group and shaken at 4°C for 1 hour. The precipitate was washed 5 times with RIPA lysate, 20 μL 1 × protein loading buffer was added to the precipitate and boiled at 100°C for 5 min, followed by SDS-PAGE and western blot. After transferring the proteins to PVDF membranes, the protein bands were incubated with rabbit anti-claudin 1, e-cadherin, occludin, collagen I, fibronectin or laminin antibody to analyze the cellular proteins interacting with rTsCatL2.

Effect of rTsCatL2 on autophagy

A final concentration of 10 μg/mL rTsCatL2, 10 μg/mL MBP, earle’s balanced salt solution (EBSS) or pH 6.5 PBS was incubated with Caco-2 cells for 60 min. The treated cells were analyzed for the induction of autophagy in Caco-2 cells using the monodansylcadaverine (MDC) Method Cell Autophagy Assay Kit (Beyotime, China). The procedure was as follows: Each well received 500 μL of MDC staining solution at 37°C for 30 min. The MDC staining solution was removed and washed with assay buffer to visualize green fluorescence under a fluorescence microscope with ultraviolet (UV) excitation light.

Normal untreated cells and cells after rTsCatL2 incubation were fixed with 2.5% glutaraldehyde for 5 min. The cells were gently scraped off with a spatula and centrifuged at 2500 g for 2 min. The cells were fixed for 2 h at room temperature in a new electron microscope fixative. After fixation, the samples were sent to Wuhan Servicebio for embedding, sectioning and observation of autophagy using transmission electron microscopy and photography.

Statistical analysis

In this study, SPSS 21.0 software was utilizied to describe and analyze experimental data using a one-way ANOVA or chi-square test, with a significance level set at P < 0.05.

Results

Effect of silencing the TsCatL gene

The qPCR results revealed that mRNA transcript levels of TsCatL were reduced in siRNA-302 and siRNA-775 treated groups at 1 day post-RNAi (dpr) (F1d = 26.25, P < 0.05). At 3 and 5 dpr, TsCatL mRNA transcript levels were reduced in siRNA-302, siRNA-775 and siRNA-1077 treated groups (F3d = 14.31, P < 0.05; F5d = 85.46, P < 0.05), and transcript levels were reduced by 44.42%, 41.06% and 39.43% in the three treatment groups at 5 dpr, respectively (Fig 1A). Western blot results showed that at 3 dpr, TsCatL protein expression was reduced by 44.07% (P < 0.05) in the siRNA-302-treated group. At 5 dpr, TsCatL protein expression was reduced by 45.58% and 39.17% (P < 0.05) in the siRNA-302 and siRNA-775 treated groups, respectively (Fig 1B). The RNAi specificity assay showed a 41.93% (P < 0.05) reduction in TsCatL protein expression in the siRNA-302-treated group at 3 day post-RNAi. In contrast, TsASP2 protein expression in the worms remained unchanged, indicating that the siRNA-302 silencing effect was specific to TsCatL only (Fig 2).

Fig 1.

Fig 1

Changes in the mRNA transcript levels (A) and protein expression levels (B) of the TsCatL gene after RNA interference. A: qPCR analysis of TsCatL mRNA transcript levels; at 3 and 5 days post-RNAi, TsCatL mRNA transcript levels decreased in siRNA-302, siRNA-775 and siRNA-1077 treated groups (*P < 0.05). B: Western blot analysis of TsCatL protein expression. At 5 days post RNAi, TsCatL protein levels reduced by 45.58% and 39.17% in siRNA-302 and siRNA-775 treated groups, respectively (*P < 0.05).

Fig 2. Gene-specific analysis of RNA interference.

Fig 2

Western blot showing changes in TsCatL and TsASP2 protein expression levels in siRNA-302-treated worms (*P < 0.05).

Effect of TsCatL in larval invasion

T. spiralis ML were added to the surface of different cell monolayers in vitro after bile activation, and some of the live worms were able to invade Caco-2 cell monolayers, leaving serpentine migration tracks on the surface of Caco-2 cells without invading C2C12 cells (Fig 3A). PI staining of the cells showed that the damaged cells were distributed in a serpentine pattern overlapping with the worm migration tracks (Fig 3B). Addition of rTsCatL2 immune serum to the surface of the cells showed a distinct bright green fluorescence of damaged cells, indicating that TsCatL2 remained in Caco-2 cells after larval invasion (Fig 3C). When anti-rTsCatL2 serum (1:50 ~ 1:200) was added to the medium, the invasion rate of worms into Caco-2 cell monolayers was 31.67%, 33.67% and 33.33%, respectively, which was lower than the invasion rate of 52.67% in the PBS group (χ21:50 = 9.023, P < 0.05; χ21:100 = 7.334, P < 0.05; χ21:200 = 8.160, P < 0.05); the inhibition rate of 1:50, 1:100 and 1:200 anti-rTsCatL2 serum was 39.87%, 36.07% and 36.72%, respectively, which was lower than the normal serum (χ21:50 = 65.864, P < 0.001; χ21:100 = 63.943, P < 0.001; χ21:200 = 67.249, *P < 0.001) (Fig 4A). Furthermore, in the TsCatL siRNA-302, control siRNA and PBS groups, the invasion rate of T. spiralis was 32.67%, 50.33% and 53.00%, respectively. The inhibition rates for the siRNA-302 group and the control siRNA group were 38.36% and 5.04%, respectively. The siRNA-302 group inhibited larval penetration into the Caco-2 cell monolayer more than the control siRNA group (χ2 = 32.262, P < 0.001) (Fig 4B). According to the aforementioned findings, TsCatL facilitated T. spiralis to invade the host epithelial cells.

Fig 3. Caco-2 cells damage caused by larval penetration.

Fig 3

A: Observation of larval invasion cell. The larva invaded Caco-2 cells (A1, the red arrow shows migratory trace); non-invaded larvae on Caco-2 (A2) and C2C12 (A3); the dead larvae on Caco-2 (A4); Scale bar: 200 μm. B: Larval invasion resulting in cell damage. B1 shows Caco-2 cells monolayer damaged by helminth invasion, stained with PI to show the red fluorescence of the cells; B2 represents undamaged Caco-2 cell monolayer; B3 shows undamaged C2C12 cell monolayer; scale bar: 200 μm. C: Fluorescence analysis of larval migrationin Caco-2 cells. After the larvae have invaded the cell monolayer, some worm proteins remain within the cells. Anti-rTsCatL2 serum and T. spiralis infection serum fluoresce green in association with worm proteins; nuclei of damaged or dead cells are stained red with PI; scale bar: 100 μm.

Fig 4. The effect of TsCatL in the larval invasion of Caco-2 cells.

Fig 4

A: Larval invasion inhibition by anti-rTsCatL2 immune serum. After adding anti-rTsCatL2 serum at 1:50, 1:100 and 1:200 ratios, the inhibition rate was 39.87%, 36.07% and 36.72%, respectively, which was lower than the normal serum (χ21:50 = 65.864, P < 0.001; χ21:100 = 63.943, P < 0.001; χ21:200 = 67.249, *P < 0.001). B: RNAi silencing of TsCatL inhibited larval invasion into Caco-2 cells. The inhibition rate of the siRNA-302 group was higher than that of the control siRNA group (χ2 = 32.262, P < 0.001).

RNAi silencing of TsCatL on worm infectivity and fecundity

ML were orally infected in mice 3 d after siRNA treatment, and 24 h IIL, 6 d AW and 35 d ML were collected and then counted, observed and measured for length under a microscope. The recoveries of IIL and AW in the TsCatL siRNA-302 group were lower than those in the control siRNA and PBS groups (FIIL = 177.34, FAW = 246.67, P < 0.05), and the reduction rates of IIL and AW were 44.37% and 47.57%, respectively. Silencing of TsCatL reduced T. spiralis invasion into the intestine of mice and reduced the worm burden in the intestine of mice. The recovered 6 d females were incubated in 1640 complete medium for 24 h, and the number of NBL produced by females in the TsCatL siRNA-302 group was lower than that in the control siRNA and PBS groups (FNBL = 6.342, P < 0.05). When the ML was collected in mice, the TsCatL siRNA-302 group had a lower worm burden than the control siRNA and PBS groups (FML = 14.421, P < 0.05) and a worm reduction rate of 57.06%. Length measurements of worms collected at different developmental stages revealed differences in the length of 6 d females between treatment groups (F = 4.326, P < 0.05) and 6 d females in the TsCatL siRNA-302 group were shorter than PBS group (P < 0.017), while the lengths of IIL, 6 d males, NBL and ML did not differ between treatment groups (FIIL = 1.306, P > 0.05; FMale = 2.118, P > 0.05; FNBL = 1.419, P > 0.05; FML = 2.772, P > 0.05) (Fig 5).

Fig 5. Effects of RNA interference on worm burden and development in mice.

Fig 5

The siRNA-treated T. spiralis ML were used to infect mice, and worms at different developmental stages were collected for counting, observation and length measurement. Compared with the control siRNA and PBS groups, the recoveries of IIL and AW were reduced in the siRNA-302-treated group (*P < 0.05), the ML worm load was reduced (*P < 0.05), and the worm reduction rates were 44.37%, 47.57% and 57.06% for IIL, AW and ML, respectively. The female worm length and fecundity were reduced in the siRNA-302-treated group (*P < 0.05). Scale bar: 200 μm.

Fluorescence detection of rTsCatL2 binding to Caco-2 cells

When rTsCatL2 was added to Caco-2 cells, the cells gradually shrank and became rounded with increasing incubation time. The tight junctions between the cells disappeared and some of the cells even fell off. In contrast, the cell morphology of the MBP and PBS groups did not change. Immunofluorescence with anti-rTsCatL2 antibody showed that rTsCatL2 bound mainly around the cell periphery at the beginning and gradually entered the cytoplasm and nucleus with increasing incubation time; when MBP and E64-treated rTsCatL2 was added to Caco-2 cells, faint fluorescence of Caco-2 cells was detected; whereas no fluorescence was seen in the heat-treated rTsCatL2 group and the PBS group (Fig 6).

Fig 6. rTsCatL2 binding to Caco-2 cells analyzed by fluorescence.

Fig 6

After co-culture of rTsCatL2 with Caco-2 cells, immunofluorescence showed that rTsCatL2 initially bound mainly around the cell periphery and gradually entered the cytoplasm with increasing incubation time. Faint fluorescence of Caco-2 cells was detected in the MBP and E64-treated rTsCatL2 groups, while no fluorescence was detected in the heat-treated rTsCatL2 group and the PBS group. Scale bar: 50 μm.

Fluorescence detection of the effect of rTsCatL2 on Caco-2 cell proteins

When rTsCatL2 was added to the surface of Caco-2 cells, immunofluorescence showed that claudin 1, e-cadherin, occludin and zo-1 were initially located at the tight junctions. After 30 min, the cells became smaller and separated from each other, claudin 1, occludin and zo-1 became smaller in outline and wrapped around each cell, and the cells became less connected to each other. However, e-cadherin aggregated into clusters and was engulfed inside the cells. After 60 min, immunofluorescence showed that claudin 1, e-cadherin, occludin and zo-1 entered the nucleus of the cells, the fluorescence of claudin 1 had disappeared in some cells, the fluorescence of e-cadherin, occludin and zo-1 was still present, and occludin and zo-1 also started to cluster (Fig 7A). Furthermore, after 60 min incubation, immunofluorescence showed that fibronectin was located in the cytoplasm, while laminin was scattered in the nucleus (Fig 7B). While the localization of cellular proteins did not change in the MBP, E64-treated rTsCatL2, and heat-treated rTsCatL2 and PBS groups.

Fig 7.

Fig 7

Fluorescence analysis of changes in rTsCatL2 after incubation with Caco-2 cells on cell junctions (A) and extracellular matrix proteins (B). Immunofluorescence showed that claudin 1, e-cadherin, occludin and zo-1 gradually entered the cells from the cell junctions, the fluorescence brightness of claudin 1 gradually decreased, laminin was scattered in the nucleus, while the localization of cellular proteins did not change in the MBP, PBS, E64-treated rTsCatL2, and heat-treated rTsCatL2 groups, scale bar: 50 μm.

Western blot analysis of Caco-2 cell proteins

The rTsCatL2 was added to Caco-2 cells and the cellular proteins were collected after incubation at different times. It was revealed that the expression of claudin 1 decreased by 43.23% after 30 min incubation and 58.65% after 60 min incubation (F = 81.66, P < 0.05). There was no significant change in the expression of e-cadherin, occludin, laminin and collagen-1 protein in Caco-2 cells (P > 0.05) (Fig 8).

Fig 8. Western blot analysis of cellular protein changes after incubation of rTsCatL2 with Caco-2 cells.

Fig 8

When rTsCatL2 was co-cultured with Caco-2 cells, the expression of claudin 1 decreased by 43.23% after 30 min incubation and by 58.65% after 60 min incubation (*P < 0.05), while the protein expression levels of e-cadherin, occludin, laminin and collagen-I did not change significantly (P > 0. 05); A: ECL chemiluminescence; B: greyscale analysis.

Co-IP assay of rTsCatL2 binding to Caco-2 cellular proteins

To investigate the interaction rTsCatL2 with cellular proteins, rTsCatL2 was incubated with Caco-2 for 30 min and immunoprecipitated. rTsCatL2 was shown not to interact with claudin 1, e-cadherin, occludin and fibronectin but with laminin and collagen I (Fig 9).

Fig 9. Co-IP analysis of rTsCatL2 interaction with Caco-2 cell proteins.

Fig 9

The result showed that rTsCatL2 interacts with laminin and collagen I but not with claudin 1, e-cadherin, occludin or fibronectin.

Role of rTsCatL2 on autophagy

After rTsCatL2 treatment, Caco-2 cells were stained for MDC fluorescence, and bright green fluorescence was observed upon excitation with UV light (Fig 10A). Transmission electron microscopy revealed the presence of autophagic vesicles and autophagic lysosomes in Caco-2 cells after incubation with rTsCatL2 (Fig 10B). The results indicated that rTsCatL2 induced autophagy in Caco-2 cells.

Fig 10. Assessment of the effect of rTsCatL2 on Caco-2 autophagy.

Fig 10

A: MDC fluorescence staining. The rTsCatL2-treated group showed bright green fluorescence and cells underwent autophagy; the EBSS-treated positive control group underwent autophagy, while no fluorescence was observed in MBP and PBS groups, scale bar: 100 μm. B. Transmission electron microscopy. M: mitochondrion; Go: Golgi apparatus; PS: foot; ASS: autolysosome; AP: autophagosome.

Discussion

The cathepsin L enzyme produced by the parasite facilitates the invasion, migration, and breakdown of host proteins into absorbable nutrients [24,25]. Our previous research demonstrated that rTsCatL2 degrades immunoglobulin, hemoglobin, fibronectin, laminin and collagen I in vitro. It also exhibits the highest transcript levels in the larval stage of intestinal infection [14]. However, the role of TsCatL in T. spiralis invasion of host epithelial cells is unclear.

RNAi technology has been successfully applied in various parasitic helminths, including Brugia malayi, Ascaris suum, T. spiralis, Haemonchus contortus and Schistosoma japonicum [26]. In studies on T. spiralis, silencing paramyosin using siRNA1743 reduced larval molting rate and caused severe epidermal damage [27]. Additionally, silencing serine protease, glutathione S-transferase reduced T. spiralis invasion of hosts, affecting worm development and fecundity [21,28,29]. Silencing glutaminase reduced larval infectivity, while silencing glutamine synthetase affected acid tolerance, molting and larval development [30,31]. In this study, three pairs of specific short-fragment siRNAs were designed to silence TsCatL by electroporation, and siRNA-302 was the most effective in silencing TsCatL. The specificity of siRNA-302 interference was then tested by selecting TsASP2, which has low homology to TsCatL. Western blotting showed that the siRNA-302 interference was specific and silenced only the TsCatL gene, which could be used for further experimental studies.

Cathepsin is a crucial digestive enzyme in the parasite. Fasciola hepatica breaks down collagen by secreting cathepsin L2 and cathepsin L3, which helps the worm to migrate through the host [32], and Schistosoma japonicum cathepsin B2, which helps the worm to invade the skin [33]. In this study, when T. spiralis larvae were added to Caco-2 cells, they invaded the cells, leaving a serpentine migration path without invading the control C2C12 cells. This selective invasion suggests that T. spiralis invasion is not purely mechanical. This result is consistent with previous studies in which T. spiralis readily invaded intestinal and renal epithelial cells but not fibroblasts and myocytes [34]. T. spiralis invaded Caco-2 cell monolayers and residues of TsCatL were detected on their migration pathways, suggesting that TsCatL was involved in the worms’ invasion of epithelial cell monolayers. The addition of rTsCatL2 immune serum to the semi-solid medium reduced the invasion, probably because the antiserum blocked the active site of TsCatL, which in turn blocked the invasion. The reduction in larval invasion by RNAi silencing of TsCatL further suggested that TsCatL is essential for larval invasion of Caco-2 cells. Mice gavaged orally with T. spiralis after RNAi silencing of TsCatL showed reduced numbers of IIL and AW recovered in the intestine and reduced ML worm loads in the muscle, indicating that fewer T. spiralis larvae invaded the intestinal mucosa of the mice and that TsCatL was involved in the T. spiralis invasion of the host intestinal mucosa. Silencing of the TsCatL gene in T. spiralis resulted in shorter lengths of 6 d females and reduced numbers of NBL, and in conjunction with previous studies that found TsCatL localized to the embryo of the worm, it is hypothesized that TsCatL is involved in embryonic development [14]. Cathepsin L of Caenorhabditis elegans is important for embryogenesis and development [35]. Silencing the Cathepsin L of Caenorhabditis elegans by RNAi or mutation would result in an almost 100% embryonic lethality rate [36]. The findings showed that silencing of the TsCatL gene reduced larval invasion of host intestinal mucosa and reduced the infectivity and fecundity in the host.

The intestinal epithelium is tightly linked to form a physical barrier in the intestine, preventing pathogens from leaving intestinal lumen and invading the host. After T. spiralis invades the intestinal mucosa, pathological sections show edema of the intestinal mucosa, an increase in the size of the small intestinal villi, an increase in cupped cells and the size of the intestinal epithelium with a hyaline, slightly stained cytoplasm [20]. Protozoa can enter the host by breaching the intestinal barrier through virulence factors. Occludin and zo-1 levels are decreased and some microvilli on the cell surface are lost when Toxoplasma gondii infects Caco-2 cells [37]. Caco-2 cells infected with Cryptosporidium parvum increased paracellular permeability and reduced protein levels of claudin 4, occludin and e-cadherin, and C57BL/6 mice infected with Cryptosporidium parvum also showed significantly reduced protein expression of occludin, claudin 4 and e-cadherin in the mucosa of the ileum and jejunum [38]. The addition of Giardia intestinalis to Caco-2 cell monolayers resulted in changes in the integrity of cellular tight junctions, microvillar structure and extracellular mucin layer [39]. The nematodes rely on a combination of mechanical forces and virulence factors to mediate worm entry into the host intestinal mucosa. Haemonchus contortus make Caco-2 cell monolayers more permeable [40]. Serine and cysteine proteases in T. spiralis IIL down-regulate the expression of occludin, claudin 1 and e-cadherin in Caco-2 cells and up-regulate the expression of claudin 2; the specific proteins that perform this function have not been identified [10]. In vitro invasion assays and RNAi results in T. spiralis demonstrated that TsCatL plays a crucial role in worm invasion of intestinal mucosa. To further analyze the reasons, rTsCatL2 was added to Caco-2 cells to analyze the effect of rTsCatL2 on cell junctions.

In this study, rTsCatL2 altered the localization of cellular tight junction proteins (claudin 1, occludin and zo-1) and adhesion-linked proteins (e-cadherin), downregulated claudin 1 expression and disrupted intestinal barrier integrity. The transmembrane protein claudin 1 is the major TJ protein in the paracellular barrier [41]. The transmembrane protein occludin is a crucial molecule regulating TJ permeability [42]. The cytoplasmic protein zo-1 is a key molecule involved in TJ assembly and signal transduction [43]. Changes in the number and localization of TJ proteins result in reduced intestinal epithelial barrier function [44].

Previous research has demonstrated that rTsCatL2 hydrolyzes host collagen I, fibronectin, and laminin in vitro, all of which are important components of the extracellular matrix (ECM), which is required for cell adhesion, signaling, migration, and metabolism [14,45]. In this study, rTsCatL2 altered the localization of laminin. However, Western blot showed no change in laminin and collagen I expression, presumably because rTsCatL2 interacts with cells for only one hour and rTsCatL2 degrades host proteins in vitro by overnight incubation [14]. Further research into rTsCatL2’s interactions with Caco-2 proteins showed that rTsCatL2 interacted with collagen I and laminin but not with claudin 1, e-cadherin, occludin, or fibronectin. The results showed that the cell barrier disruption by rTsCatL2 does not rely solely on its hydrolysis but that there are other regulatory mechanisms. Studies showed that T. spiralis excretion/secretion proteins inhibited the expression of tight junction proteins via the MAPK signaling pathway [9]. Piezo1, a mechanosensitive and nonselective cation channel, regulates intestinal epithelial function by affecting the tight junction protein claudin-1 via the ROCK pathway [46]. L-glutamine led to an increased distribution of claudin-1 at plasma membranes in intestinal porcine epithelial cells by activating CAMKK2-AMPK signaling [47].

Cryptosporidium parvum was found to reduce the expression of occludin, claudin-4 and e-cadherin through autophagy, disrupting the epithelial barrier. siRNA silencing of the autophagy-associated protein ATG7 in Caco-2 cells blocked Cryptosporidium-induced downregulation of occludin, claudin-4 and e-cadherin [48]. Incubation of Entamoeba histolytica trophoblast extracts with MDCK cells in lysogenic tissue causes cell death by autophagy, leading to the destruction of the epithelial cell barrier [49]. In this study, fluorescence and projection electron microscopy results indicated that autophagy occurred in Caco-2 cells after incubation with rTsCatL2. The decrease of claudin 1 and the alteration in TJ/AJ localization may be associated with autophagy, leading to the disruption of intestinal epithelial barrier function.

In conclusion, after RNAi silenced TsCatL, the level of TsCatL transcription and expression in the worms decreased, the invasion rate of worms into Caco-2 decreased, and the development and fertility of the female worm were inhibited. Incubating rTsCatL2 with Caco-2 cells resulted in the loss of intercellular junctions, entry of cell junction proteins into the cytoplasm and cell autophagy, leading to disruption of the intestinal epithelial barrier. This study offers a novel target for the development of anti-trichinosis vaccines and drugs.

Data Availability

All relevant data are included in the paper.

Funding Statement

RDL was supported by the National Natural Science Foundation of China (81802025) and Henan Province Science and Technology key project (212102310146); JC was supported by the National Natural Science Foundation of China (No. 82172300). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Rostami A, Gamble HR, Dupouy-Camet J, Khazan H, and Bruschi F. (2017) Meat sources of infection for outbreaks of human trichinellosis. Food Microbiol 64: 65–71. doi: 10.1016/j.fm.2016.12.012 [DOI] [PubMed] [Google Scholar]
  • 2.Wang ZQ, Liu RD, Sun GG, Song YY, Jiang P, et al. (2017) Proteomic Analysis of Trichinella spiralis adult worm excretory-secretory proteins recognized by sera of patients with early trichinellosis. Front Microbiol 8: 986. doi: 10.3389/fmicb.2017.00986 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Otani T, and Furuse M. (2020) Tight junction structure and function revisited. Trends Cell Biol 30: 805–817. doi: 10.1016/j.tcb.2020.08.004 [DOI] [PubMed] [Google Scholar]
  • 4.Cong X, Zhang Y, Yu GY, and Wu LL. (2016) Research progress on the function of epithelial tight junction. Sheng Li Xue Bao 68: 492–504. [PubMed] [Google Scholar]
  • 5.Yan SW, Hu YY, Song YY, Ren HN, Shen JM, et al. (2021) Characterization of a Trichinella spiralis cathepsin X and its promotion for the larval invasion of mouse intestinal epithelial cells. Vet Parasitol 297: 109160. doi: 10.1016/j.vetpar.2020.109160 [DOI] [PubMed] [Google Scholar]
  • 6.Xu J, Liu RD, Bai SJ, Hao HN, Yue WW, et al. (2020) Molecular characterization of a Trichinella spiralis aspartic protease and its facilitation role in larval invasion of host intestinal epithelial cells. Plos Neglect Trop Dis 14: e0008269. doi: 10.1371/journal.pntd.0008269 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang L, Wang ZQ, and Cui J. (2013) Protein changes in Trichinella spiralis muscle larvae in vitro induced by bovine bile. Vet Parasitol 194: 164–167. doi: 10.1016/j.vetpar.2013.01.046 [DOI] [PubMed] [Google Scholar]
  • 8.Wang ZQ, Wang L, and Cui J. (2012) Proteomic analysis of Trichinella spiralis proteins in intestinal epithelial cells after culture with their larvae by shotgun LC-MS/MS approach. J Proteomics 75: 2375–2383. doi: 10.1016/j.jprot.2012.02.005 [DOI] [PubMed] [Google Scholar]
  • 9.Li C, Bai X, Liu X, Zhang Y, Liu L, et al. (2021) Disruption of epithelial barrier of Caco-2 cell monolayers by excretory secretory products of Trichinella spiralis might be related to serine protease. Front Microbiol. 12:634185. doi: 10.3389/fmicb.2021.634185 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Song YY, Lu QQ, Han LL, Yan SW, Zhang XZ, et al. (2022) Proteases secreted by Trichinella spiralis intestinal infective larvae damage the junctions of the intestinal epithelial cell monolayer and mediate larval invasion. Vet. Res. 53: 19. doi: 10.1186/s13567-022-01032-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fernadez-Blanco JA, Estevez J, Shea-Donohue T, Martinez V, and Vergara P. (2015) Changes in epithelial barrier function in response to parasitic infection: implications for IBD pathogenesis. J Crohns Colitis 9: 463–476. doi: 10.1093/ecco-jcc/jjv056 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hasnain SZ, McGuckin MA, Grencis RK, and Thornton DJ. (2012) Serine protease(s) secreted by the nematode Trichuris muris degrade the mucus barrier. Plos Neglect Trop Dis 6: e1856. doi: 10.1371/journal.pntd.0001856 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ortega-Pierres G, Arguello-Garcia R, Laredo-Cisneros MS, Fonseca-Linan R, Gomez-Mondragon M, et al. (2018) Giardipain-1, a protease secreted by Giardia duodenalis trophozoites, causes junctional, barrier and apoptotic damage in epithelial cell monolayers. Int J Parasitol 48: 621–639. doi: 10.1016/j.ijpara.2018.01.006 [DOI] [PubMed] [Google Scholar]
  • 14.Liu RD, Meng XY, Li CL, Long SR, Cui J, et al. (2022) Molecular characterization and determination of the biochemical properties of cathepsin L of Trichinella spiralis. Vet Res 53: 48. doi: 10.1186/s13567-022-01065-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Gamble HR, Bessonov AS, Cuperlovic K, Gajadhar AA, van Knapen F, et al. (2000) International Commission on Trichinellosis: recommendations on methods for the control of Trichinella in domestic and wild animals intended for human consumption. Vet Parasitol 93: 393–408. doi: 10.1016/s0304-4017(00)00354-x [DOI] [PubMed] [Google Scholar]
  • 16.Jiang P, Wang ZQ, Cui J, and Zhang X. (2012) Comparison of artificial digestion and Baermann’s methods for detection of Trichinella spiralis pre-encapsulated larvae in muscles with low-level infections. Foodborne Pathog Dis 9: 27–31. doi: 10.1089/fpd.2011.0985 [DOI] [PubMed] [Google Scholar]
  • 17.Liu RD, Cui J, Liu XL, Jiang P, Sun GG, et al. (2015) Comparative proteomic analysis of surface proteins of Trichinella spiralis muscle larvae and intestinal infective larvae. Acta Trop 150: 79–86. doi: 10.1016/j.actatropica.2015.07.002 [DOI] [PubMed] [Google Scholar]
  • 18.Liu RD, Wang ZQ, Wang L, Long SR, Ren HJ, et al. (2013) Analysis of differentially expressed genes of Trichinella spiralis larvae activated by bile and cultured with intestinal epithelial cells using real-time PCR. Parasitol Res 112: 4113–4120. doi: 10.1007/s00436-013-3602-1 [DOI] [PubMed] [Google Scholar]
  • 19.Ren HN, Bai SJ, Wang Z, Han LL, Yan SW, et al. (2021) A metalloproteinase Tsdpy31 from Trichinella spiralis participates in larval molting and development. Int J Biol Macromol 192: 883–894. doi: 10.1016/j.ijbiomac.2021.10.021 [DOI] [PubMed] [Google Scholar]
  • 20.Xu J, Yue WW, Xu YXY, Hao HN, Liu RD, et al. (2021) Molecular characterization of a novel aspartyl protease-1 from Trichinella spiralis. Res Vet Sci 134: 1–11. doi: 10.1016/j.rvsc.2020.11.008 [DOI] [PubMed] [Google Scholar]
  • 21.Yang DQ, Liu F, Bai Y, Zeng J, Hao HN, et al. (2021) Functional characterization of a glutathione S-transferase in Trichinella spiralis invasion, development and reproduction. Vet Parasitol 297: 109128. doi: 10.1016/j.vetpar.2020.109128 [DOI] [PubMed] [Google Scholar]
  • 22.Liu RD, Qi X, Sun GG, Jiang P, Zhang X, et al. (2016) Proteomic analysis of Trichinella spiralis adult worm excretory-secretory proteins recognized by early infection sera. Vet Parasitol 231: 43–46. doi: 10.1016/j.vetpar.2016.10.008 [DOI] [PubMed] [Google Scholar]
  • 23.Xu J, Liu RD, Long SR, Song YY, Jiang P, et al. (2020) Characterization of a chymotrypsin-like enzyme from Trichinella spiralis and its facilitation of larva penetration into the host’s enteral epithelial cells. Res Vet Sci 128: 1–8. doi: 10.1016/j.rvsc.2019.10.018 [DOI] [PubMed] [Google Scholar]
  • 24.Caffrey CR, Goupil L, Rebello KM, Dalton JP, and Smith D. (2018) Cysteine proteases as digestive enzymes in parasitic helminths. Plos Neglect Trop Dis 12: 20. doi: 10.1371/journal.pntd.0005840 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Grote A, Caffrey CR, Rebello KM, Smith D, Dalton JP, et al. (2018) Cysteine proteases during larval migration and development of helminths in their final host. Plos Neglect Trop Dis 12: 8. doi: 10.1371/journal.pntd.0005919 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dalzell JJ, McVeigh P, Warnock ND, Mitreva M, Bird DM, et al. (2011) RNAi Effector Diversity in Nematodes. Plos Neglect Trop Dis 5: e117610. doi: 10.1371/journal.pntd.0001176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chen XQ, Yang YP, Yang J, Zhang ZF, and Zhu XP. (2012) RNAi-mediated silencing of paramyosin expression in Trichinella spiralis results in impaired viability of the parasite. Plos One 7: e49913. doi: 10.1371/journal.pone.0049913 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Yang DQ, Zeng J, Sun XY, Yue X, Hu CX, et al. (2020) Trichinella spiralis: RNAi-mediated silencing of serine protease results in reduction of intrusion, development and fecundity. Tropical Biomedicine 37: 932–946. doi: 10.47665/tb.37.4.932 [DOI] [PubMed] [Google Scholar]
  • 29.Yang F, Guo KX, Yang DQ, Liu RD, Long SR, et al. (2020) Functional analysis of Trichinella spiralis serine protease 1.2 by siRNA mediated RNA interference. Trop Biomed 37: 458–470. [PubMed] [Google Scholar]
  • 30.Gao Y, Meng XQ, Yang X, Meng S, Han CX, et al. (2021) RNAi-mediated silencing of Trichinella spiralis glutaminase results in reduced muscle larval infectivity. Vet Res 52: 51. doi: 10.1186/s13567-021-00921-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhuo TX, Wang Z, Song YY, Yan SW, Liu RD, et al. (2021) Characterization of a novel glutamine synthetase from Trichinella spiralis and its participation in larval acid resistance, molting, and development. Front Cell Dev Biol 9: 729402. doi: 10.3389/fcell.2021.729402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Robinson MW, Corvo I, Jones PM, George AM, Padula MP, et al. (2011) Collagenolytic activities of the major secreted cathepsin L peptidases involved in the virulence of the helminth pathogen, Fasciola hepatica. Plos Neglect Trop Dis 5: e1012. doi: 10.1371/journal.pntd.0001012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhu BK, Luo F, Shen Y, Yang WB, Sun CS, et al. (2020) Schistosoma japonicum cathepsin B2 (SjCB2) facilitates parasite invasion through the skin. Plos Neglect Trop Dis 14: e0008810. doi: http%3A//doi.org/10.1371/journal.pntd.0008810 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.ManWarren T, Gagliardo L, Geyer J, McVay C, PearceKelling S, et al. (1997) Invasion of intestinal epithelia in vitro by the parasitic nematode Trichinella spiralis. Infect Immun 65: 4806–4812. doi: 10.1128/iai.65.11.4806-4812.1997 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Britton C, and Murray L. (2006) Using Caenorhabditis elegans for functional analysis of genes of parasitic nematodes. Int J Parasitol 36: 651–659. doi: 10.1016/j.ijpara.2006.02.010 [DOI] [PubMed] [Google Scholar]
  • 36.Hashmi S, Britton C, Liu J, Guiliano DB, Oksov Y, et al. (2002) Cathepsin L is essential for embryogenesis and development of Caenorhabditis elegans. J Biol Chem 277: 3477–3486. doi: 10.1074/jbc.M106117200 [DOI] [PubMed] [Google Scholar]
  • 37.Briceno MP, Nascimento LAC, Nogueira NP, Barenco PVC, Ferro EAV, et al. (2016) Toxoplasma gondii infection promotes epithelial barrier dysfunction of Caco-2 cells. J Histochem Cytochem 64: 459–469. doi: 10.1369/0022155416656349 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Kumar A, Chatterjee I, Anbazhagan AN, Jayawardena D, Priyamvada S, et al. (2018) Cryptosporidium parvum disrupts intestinal epithelial barrier function via altering expression of key tight junction and adherens junction proteins. Cell Microbiol 20: e12830. doi: 10.1111/cmi.12830 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Ma’ayeh SY, Knorr L, Skold K, Garnham A, Ansell BRE, et al. (2018) Responses of the differentiated intestinal epithelial cell line Caco-2 to infection with the Giardia intestinalis GS isolate. Front Cell Infect Microbiol 8:244. doi: 10.3389/fcimb.2018.00244 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rehman ZU, Deng Q, Umair S, Savoian MS, Knight JS, et al. (2016) Excretory/secretory products of adult Haemonchus contortus and Teladorsagia circumcincta which increase the permeability of Caco-2 cell monolayers are neutralised by antibodies from immune hosts. Vet Parasitol 221: 104–110. doi: 10.1016/j.vetpar.2016.03.017 [DOI] [PubMed] [Google Scholar]
  • 41.Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, et al. (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156: 1099–1111. doi: 10.1083/jcb.200110122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Saitou M, Furuse M, Sasaki H, Schulzke JD, Fromm M, et al. (2000) Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11: 4131–4142. doi: 10.1091/mbc.11.12.4131 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Tornavaca O, Chia MH, Dufton N, Almagro LO, Conway DE, et al. (2015) Zo-1 controls endothelial adherens junctions, cell-cell tension, angiogenesis and barrier formation. Anticancer Res 35: 4304–4305. doi: 10.1083/jcb.201404140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Schmitz H, Barmeyer C, Fromm M, Runkel N, Foss HD, et al. (1999) Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis. Gastroenterology 116: 301–309. doi: 10.1016/s0016-5085(99)70126-5 [DOI] [PubMed] [Google Scholar]
  • 45.Theocharis AD, Skandalis SS, Gialeli C, and Karamanos NK. (2016) Extracellular matrix structure. Adv Drug Deliv Rev 97: 4–27. doi: 10.1016/j.addr.2015.11.001 [DOI] [PubMed] [Google Scholar]
  • 46.Jiang Y, Song J, Xu Y, Liu C, Qian W, et al. (2021) Piezo1 regulates intestinal epithelial function by affecting the tight junction protein claudin-1 via the ROCK pathway. Life Sci. 275:119254. doi: 10.1016/j.lfs.2021.119254 [DOI] [PubMed] [Google Scholar]
  • 47.Wang B, Wu Z, Ji Y, Sun K, Dai Z, et al. (2016) L-glutamine enhances tight junction integrity by activating CaMK kinase 2-AMP-activated protein kinase signaling in intestinal porcine epithelial cells. J Nutr. 146:501–508. doi: 10.3945/jn.115.224857 [DOI] [PubMed] [Google Scholar]
  • 48.Priyamvada S, Jayawardena D, Bhalala J, Kumar A, Anbazhagan AN, et al. (2021) Cryptosporidium parvum infection induces autophagy in intestinal epithelial cells. Cell Microbiol 23: e13298. doi: 10.1111/cmi.13298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Betanzos A, Javier-Reyna R, Garcia-Rivera G, Banuelos C, Gonzalez-Mariscal L, et al. (2013) The EhCPADH112 complex of Entamoeba histolytica interacts with tight junction proteins occludin and claudin-1 to produce epithelial damage. Plos One 8: e65100. doi: 10.1371/journal.pone.0065100 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011816.r001

Decision Letter 0

Francesca Tamarozzi, Krystyna Cwiklinski

1 Aug 2023

Dear Professor Cui,

Thank you very much for submitting your manuscript "Trichinella spiralis cathepsin L damages the tight junctions of intestinal epithelial cells and mediates larval invasion" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

The reviewers commented that this is an interesting study, however, editing and potentially other experiments are required before the manuscript is suitable for publication. Please ensure that sufficient information is provided for the methods and address all the comments raised by the reviewers.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Krystyna Cwiklinski, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Francesca Tamarozzi

Section Editor

PLOS Neglected Tropical Diseases

***********************

The reviewers commented that this is an interesting study, however, editing and potentially other experiments are required before the manuscript is suitable for publication. Please ensure that sufficient information is provided for the methods and address all the comments raised by the reviewers.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: Methods, line 136. What is the anti-rTsASP2 serum mentioned? Define this and how it was produced.

For Western blotting, how much soluble lysate was added per well? How was this quantified?

Figure 1 – how many biological replicates of the RNAi experiment have been performed? This should be clearly stated in the text/legend.

How was the % protein expression (Figure 1) quantified? More detail should be added to line 175 in the methods section.

Reviewer #2: The methods used are appropriate and the results support the conclusions.

1. Line 191,how to obtain "anti-MBP serum" should be describe clearly ;

2. Line 209~211, “rTsCatL2, MBP or PBS were ...... added to the surface of Caco-2 cells”,MBP here is protein-tag, how to obtain MBP? also expressed in E.coli and purified? or Purchased from the company?

3. The abbreviation that first appears should indicated,such as NBL, EBSS.

Reviewer #3: The methods are well described.

Study design could include addition of specific inhibitor such as E64 to rTsCL2 to show that inhibitor-bound cysteine protease does not affect Caco2 cells. Also, why did authors only test one concentration of enzyme - was the effect of the protease titratable?

In experiments where anti-TsCL2 was used to block parasite entry into cells - reduced at low significance - specificity could have been shown by adding rTsCL2 to the medium and demonstrating that this reversed the effect of the enzyme

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: What time point post-RNAi is shown in Figure 2? Please add.

It would be of interest to see if the cellular damage shown in Figure 3 is due only to the mechanical action of worms migrating through the monolayer as whether secreted products contribute as well. Could this assay be performed with the addition of dead worms as well as T. spiralis secreted products and recombinant TsCatL2?

Additionally, experiments with heat-denatured enzyme (or enzyme inhibited with E-64) would show whether these effects are due to active enzyme (same for later experiments; e.g. Fig 7 and the pulldown in Fig. 9).

Figure 4 – I don’t think it is necessary to plot the data as both & % invasion and % inhibition. Pick one readout for this figure.

How many individual works were measured in each group (Figure 5)?

Results describing Figure 6. It is stated in text that “Immunofluorescence with anti-rTsCatL2 antibody showed that rTsCatL2 bound mainly to the tight junctions of Caco-2 cells…”. It is not possible to say for certain what the TsCatL2 is binding to at this resolution. At best you can say green fluorescence was seen around the cell periphery. This section should be tempered to reflect this.

Collagen is misspelt as “collage” in several places throughout the manuscript.

The labelling of the micrographs shown in Figure 10 are too small/unclear. How many cells/field of view were observed/counted to quantify autophagy at the ultrastructural level?

Reviewer #2: The results are clearly and believable,and several minor problems should be noted.

1. Line 321~324,“rTsCatL2 bound mainly to the tight junctions of Caco-2 cells..., no binding of MBP to Caco-2 cells was detected.” actually, Fig 6, MBP-tag showed faint fluorescenec,you should describe more accurately.

2. Fig 8 and Fig 9 seem to be contradictory. Fig 8, the rTsCatL2 was added to Caco-2 cells, western blot showed no change in laminin and collagen I expression; and Fig 9, showed rTsCatL2 did not interact with claudin 1, e-cadherin, occludin and fibronectin but with collagen I and laminin. How to explain?

Reviewer #3: The amount of knockdown by iRNA is shown to be specific and significant but is nevertheless low - less than 50% with all iRNAs and for transcripts and protein -and it does not add confidence that parasites with only this reduction would be necessarily damaged and lack viability.

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: Since the silencing/antibody blocking of TsCatL2 was only partially successful at blocking entry of the worms into the epithelial cells, could the authors please speculate on other enzymes that may be compensating and the implications of this for parasite control.

Reviewer #2: (No Response)

Reviewer #3: I feel that most experiments do not achieve strong significance in parasite invasion or infectivity and additional experiments as suggested above would strengthen the data

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Line 358 – previous research?

Reviewer #2: Minor revision. The quality of English needs improving, I suggest that you obtain assistance from a colleague whose native language is English.

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: In this study the authors aimed to investigate the role of Trichinella spiralis cathepsin L (TsCatL2) during penetration of intestinal epithelial cells. Invasion of cells in vitro, as well as establishment of infection of mice, were both reduced when TsCatL2 was silenced using RNAi. They propose a mechanism for this where TsCatL2 disrupts the barrier function of the intestine by degradation of extracellular matrix/cell junction proteins.

Specific comments:

Introduction, line 106. Replace “substance” with “cysteine peptidase” to describe Giardipain-1 here.

Introduction, line 109. Explain what domains TsCatL2 refers to – was only the mature enzyme domain cloned and expressed as a recombinant?

Do the authors have any information on the transcriptional profile of TsCatL? Is it specifically upregulated to coincide with arrival of the worms in the intestine? This should be included if known.

Line 376 – it should be made clear that Fasciola hepatica secretes a large family of cathepsins L, only some of which (primarily FhCL2 and FhCL3) have collagenolytic activity.

The section of ECM/cell junctions in the discussion was overlong and could be made more concise.

Suggested further experiments are suggested in the results comments.

Reviewer #2: The topic is novel and interesting, and the methods used are appropriate. "MBP" I mentioned above is important, for rTsCatL2 were expressed in Escherichia coli, recombinant protein of Prokaryotic expression may contain endotoxins,it should avoid the effect of endotoxins on Caco-2 cell junctions, when you observe the effect of rTsCatL2 on Caco-2 cell junctions.

Reviewer #3: The data could be improved by better experimental design and control experiments as suggested above e.g. titrating protease, using specific inhibitors, uisng reverse inhibtion of antibodies.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011816.r003

Decision Letter 1

Francesca Tamarozzi, Krystyna Cwiklinski

1 Nov 2023

Dear Professor Cui,

Thank you very much for submitting your manuscript "Trichinella spiralis cathepsin L damages the tight junctions of intestinal epithelial cells and mediates larval invasion" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

The authors have addressed the reviewers comments, however some minor points still need addressing before the manuscript is suitable for publication.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Krystyna Cwiklinski, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Francesca Tamarozzi

Section Editor

PLOS Neglected Tropical Diseases

***********************

The authors have addressed the reviewers comments, however some minor points still need addressing before the manuscript is suitable for publication.

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: 1. the sequence of TsCatL2 should have signal peptide, when construct pMAL-c2X/TsCatL2 recombinant plasmid, contained the signal peptide ?

Reviewer #3: Authors have addressed my concerns and improved figures as suggested.

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: 1. Line 308,“in the TsCatL siRNA-487”, and line 310 "lower in the siRNA-487 group than in the control siRNA...Fig 4B", I'm not find siRNA-487 in the methods, and Fig 4B showed siRNA-302, but the legend is siRNA-487 group, maybe an error?

2. legend of Fig4, "the rate of worm invasion was lower in the siRNA-487 group", the picture showed inhibition%, be consistent.

3. Fig 6 and Fig 7, rTsCatL2,MBP, rTsCatL2+E64, incubation with Caco-2 cells within 60min, your response mentioned "because adding rTsCatL2 to the liquid medium severely damaged the Caco-2 cell monolayer within 1 hour", if co-culture of MBP and rTsCatL2+E64 with Caco-2 cells more than 1h, whether the similar appearance ?

Reviewer #3: Yes

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: Yes

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: None

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: (No Response)

Reviewer #2: rTsCatL2 downregulated claudin 1 expression, but not interacted with claudin 1, what's the possible mechanisms, should further discussed.

Reviewer #3: Paper is much improved

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article's retracted status in the References list and also include a citation and full reference for the retraction notice.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011816.r005

Decision Letter 2

Francesca Tamarozzi, Krystyna Cwiklinski

22 Nov 2023

Dear Professor Cui,

We are pleased to inform you that your manuscript 'Trichinella spiralis cathepsin L damages the tight junctions of intestinal epithelial cells and mediates larval invasion' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Krystyna Cwiklinski, PhD

Academic Editor

PLOS Neglected Tropical Diseases

Francesca Tamarozzi

Section Editor

PLOS Neglected Tropical Diseases

***********************************************************

The authors have addressed the comments raised by the reviewers. The manuscript is now suitable for publication in PLoS NTD.

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0011816.r006

Acceptance letter

Francesca Tamarozzi, Krystyna Cwiklinski

25 Nov 2023

Dear Professor Cui,

We are delighted to inform you that your manuscript, "Trichinella spiralis cathepsin L damages the tight junctions of intestinal epithelial cells and mediates larval invasion," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to comments on PNTD-D-23-00702.docx

    Attachment

    Submitted filename: Response to comments on PNTD-D-23-00702.docx

    Data Availability Statement

    All relevant data are included in the paper.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES